Vascular protective effects of ACE inhibitors and calcium antagonists: Theoretical basis for a combination therapy in hypertension and other cardiovasular diseases

This publication has 64 references indexed in Scilit:

• Is microalbuminuria a marker of early intrarenal vascular dysfunction in essential hypertension?
  Hypertension, 1994
• Microalbuminuria in salt-sensitive patients. A marker for renal and cardiovascular risk factors.
  Hypertension, 1994
• Angiotensin-converting enzyme inhibition with fosinopril sodium in the prevention of restenosis after coronary angioplasty.
  Circulation, 1994
• The pathogenesis of atherosclerosis: a perspective for the 1990s
  Nature, 1993
• Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
  Circulation, 1992
• Endothelin stimulated by angiotensin II augments contractility of spontaneously hypertensive rat resistance arteries.
  Hypertension, 1992
• Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells.
  Journal of Clinical Investigation, 1989
• Short- and Long-Term Determinants of Cardiovascular Function and Therapy
  Journal of Cardiovascular Pharmacology, 1989
• The anti‐aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide
  British Journal of Pharmacology, 1987
• The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine
  Nature, 1980